BVA policy on farm animal welfare.

BVA policy on animal welfare. Vet Rec (1992) 2.66

Policy on farm animal welfare. Vet Rec (1991) 1.06

Policy on farm animal welfare. Vet Rec (1991) 0.75

Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65

Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84

Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99

New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52

Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47

Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64

Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71

Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab (1982) 5.60

Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95

Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86

Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60

Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42

Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24

Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07

Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet (1992) 3.85

Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57

In vitro production of choleragen and vascular permeability factor by Vibrio cholerae. J Bacteriol (1968) 3.52

Measles, mumps, and rubella vaccine: time for a two stage policy? BMJ (1992) 3.26

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16

Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04

Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03

Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03

Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00

Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94

Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82

Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78

Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65

Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64

Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63

Measles immunisation: results of a local programme to increase vaccine uptake. Br Med J (Clin Res Ed) (1985) 2.60

Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46

Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45

Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun (1996) 2.40

The 5'-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J Virol (1994) 2.32

Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21

Measles, mumps, and rubella: the need for a change in immunisation policy. Br Med J (Clin Res Ed) (1986) 2.17

Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13

The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci (1972) 2.11

Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07

Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07

Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00

Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet (1988) 1.99

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med (1991) 1.97

The 3' untranslated region of picornavirus RNA: features required for efficient genome replication. J Virol (1995) 1.96

Membrane adenosine triphosphatase of Escherichia coli: activation by calcium ion and inhibition by monovalent cations. J Bacteriol (1969) 1.96

Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) (1984) 1.93

The effect of endurance training on parameters of aerobic fitness. Sports Med (2000) 1.92

Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun (1997) 1.90

Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet (1983) 1.87

Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85

EU ban on four antibiotic feed additives. Vet Rec (1999) 1.84

Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82

Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics (1991) 1.82

Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med (1975) 1.81

Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab (1983) 1.79

Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol (1990) 1.74

Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism (1984) 1.74

Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology (1992) 1.74

Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest (1984) 1.68

Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med (1995) 1.67

Biology of serum amyloid P component. Ann N Y Acad Sci (1982) 1.65

The dental caries experience of 14-year-old children in the United Kingdom. Surveys coordinated by the British Association for the Study of Community Dentistry in 1994/95. Community Dent Health (1996) 1.64

Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol (2004) 1.62

The energy cost of fat and protein deposition in the rat. Br J Nutr (1977) 1.62

Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol (1993) 1.61

General dental practitioners' perception of their role within child protection: a qualitative study. Eur J Paediatr Dent (2003) 1.60

In-situ and invasive carcinoma of the colon in patients with ulcerative colitis. Gut (1972) 1.59

Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infection. Gastroenterology (1992) 1.59

The influence of lesion type on the duration of hyperalgesia associated with hindlimb lameness in dairy cattle. Vet J (1998) 1.58

Inhibition of immune hemolysis: serological assay for the heat-labile enterotoxin of Excherichia coli. J Clin Microbiol (1977) 1.58

Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58

Helicobacter pylori catalase. J Gen Microbiol (1991) 1.54

Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53

In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol (1989) 1.52

Receptor-mediated adherence of Campylobacter pylori to mouse Y-1 adrenal cell monolayers. Infect Immun (1989) 1.50

Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology (1993) 1.49

Ventilation, air hygiene and animal health. Vet Rec (1983) 1.48

Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology (1992) 1.47

Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol (1990) 1.47

Gallbladder vasculitis: a report of two cases. Histopathology (1993) 1.46

Growth rate control of adherent bacterial populations. Appl Environ Microbiol (1989) 1.45

Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol (1989) 1.44

Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol (1991) 1.44

Low point prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection. Am J Gastroenterol (1996) 1.44

Large-scale preparation of gliadin proteins. J Sci Food Agric (1973) 1.42

Malignant lymphoma of parotid associated with Mikulicz disease (benign lymphoepithelial lesion). J Clin Pathol (1971) 1.40

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int (1991) 1.40

The energetic efficiency of metabolism. Proc Nutr Soc (1981) 1.40

The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40

Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med (1983) 1.39

Influence of media supplements on growth and survival of Campylobacter pylori. Eur J Clin Microbiol Infect Dis (1989) 1.39

Fluoride supplements. Br Dent J (1989) 1.39

Computation of the viscosity of a liquid from time averages of stress fluctuations. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.39

Intrasellar epithelial cysts. J Neurosurg (1966) 1.38

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J Virol (1997) 1.38